C4 Therapeutics, Inc.
cemsidomide
Multiple Myeloma
Countdown
358days
Catalyst readout · ~ Jun 30, 2027 estimated
What's at stake
A key catalyst for cemsidomide (Multiple Myeloma) is expected ~ Jun 30, 2027.
Primary source
· SEC 8-K
verified 14h ago
“Mid-2027: Present Phase 1b data from all cohorts in combination w/ elranatamab1”